The introduction of antigen into animals causes antigen-specific T cells to divide and then die. Activated T cell death requires either of the death effector molecules, Bak or Bax. When T cells die, Bak and Bax change their conformations, a phenomenon that is thought to be required for Bak or Bax to drive cell death. Here we show that Bak changes conformation before activated T cells die, as detected by an antibody specific for a peptide near the NH2 terminus of Bak, but Bax does not change its shape markedly until after the cells are dead, as detected by an antibody specific for a peptide near the NH2 terminus of Bax. This latter finding is also true in activated T cells that lack Bak and are therefore dependent on Bax to die. This result suggests that Bax does not have to adopt its final, completely unfolded form until after the cells are dead.
Skip Nav Destination
Article navigation
15 May 2006
Brief Definitive Report|
May 01 2006
Bax does not have to adopt its final form to drive T cell death
Yanan Zhu,
Yanan Zhu
1Department of Biochemistry and Molecular Genetics
Search for other works by this author on:
Xinqi Liu,
Xinqi Liu
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
David Hildeman,
David Hildeman
5Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229
Search for other works by this author on:
Fred W. Peyerl,
Fred W. Peyerl
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
Janice White,
Janice White
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
Elenora Kushnir,
Elenora Kushnir
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
John Kappler,
John Kappler
2Department of Pharmacology,
3Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80220
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
Philippa Marrack
Philippa Marrack
1Department of Biochemistry and Molecular Genetics
3Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80220
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
Yanan Zhu
1Department of Biochemistry and Molecular Genetics
Xinqi Liu
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
David Hildeman
5Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229
Fred W. Peyerl
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Janice White
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Elenora Kushnir
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
John Kappler
2Department of Pharmacology,
3Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80220
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Philippa Marrack
1Department of Biochemistry and Molecular Genetics
3Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80220
4Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
CORRESPONDENCE Philippa Marrack: [email protected]
Received:
August 26 2005
Accepted:
March 09 2006
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2006
J Exp Med (2006) 203 (5): 1147–1152.
Article history
Received:
August 26 2005
Accepted:
March 09 2006
Citation
Yanan Zhu, Xinqi Liu, David Hildeman, Fred W. Peyerl, Janice White, Elenora Kushnir, John Kappler, Philippa Marrack; Bax does not have to adopt its final form to drive T cell death . J Exp Med 15 May 2006; 203 (5): 1147–1152. doi: https://doi.org/10.1084/jem.20051736
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement